Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies

Emily R. Holzinger, Marylyn Deriggi Ritchie

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of complex phenotypes, much of the estimated heritability, or trait variability due to genetic factors, remain unexplained. We may be able to account for a portion of the missing heritability if we incorporate a systems biology approach into these analyses. Rapid technological advances will make it possible for scientists to explore this hypothesis via the generation of high-throughput omics data-transcriptomic, proteomic and methylomic to name a few. Analyzing this 'meta-dimensional data will require clever statistical techniques that allow for the integration of qualitative and quantitative predictor variables. For this article, we examine two major categories of approaches for integrated data analysis, give examples of their use in experimental and in silico datasets, and assess the limitations of each method.

Original languageEnglish (US)
Pages (from-to)213-222
Number of pages10
JournalPharmacogenomics
Volume13
Issue number2
DOIs
StatePublished - Jan 1 2012

Fingerprint

Genetic Research
Systems Biology
Pharmacogenetics
Medical Genetics
Computer Simulation
Proteomics
Names
RNA
Phenotype
Pharmaceutical Preparations
Genes
Datasets

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Holzinger, Emily R. ; Ritchie, Marylyn Deriggi. / Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies. In: Pharmacogenomics. 2012 ; Vol. 13, No. 2. pp. 213-222.
@article{4681c3b7417a465693bf4c7fbf849b3c,
title = "Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies",
abstract = "The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of complex phenotypes, much of the estimated heritability, or trait variability due to genetic factors, remain unexplained. We may be able to account for a portion of the missing heritability if we incorporate a systems biology approach into these analyses. Rapid technological advances will make it possible for scientists to explore this hypothesis via the generation of high-throughput omics data-transcriptomic, proteomic and methylomic to name a few. Analyzing this 'meta-dimensional data will require clever statistical techniques that allow for the integration of qualitative and quantitative predictor variables. For this article, we examine two major categories of approaches for integrated data analysis, give examples of their use in experimental and in silico datasets, and assess the limitations of each method.",
author = "Holzinger, {Emily R.} and Ritchie, {Marylyn Deriggi}",
year = "2012",
month = "1",
day = "1",
doi = "10.2217/pgs.11.145",
language = "English (US)",
volume = "13",
pages = "213--222",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "2",

}

Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies. / Holzinger, Emily R.; Ritchie, Marylyn Deriggi.

In: Pharmacogenomics, Vol. 13, No. 2, 01.01.2012, p. 213-222.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies

AU - Holzinger, Emily R.

AU - Ritchie, Marylyn Deriggi

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of complex phenotypes, much of the estimated heritability, or trait variability due to genetic factors, remain unexplained. We may be able to account for a portion of the missing heritability if we incorporate a systems biology approach into these analyses. Rapid technological advances will make it possible for scientists to explore this hypothesis via the generation of high-throughput omics data-transcriptomic, proteomic and methylomic to name a few. Analyzing this 'meta-dimensional data will require clever statistical techniques that allow for the integration of qualitative and quantitative predictor variables. For this article, we examine two major categories of approaches for integrated data analysis, give examples of their use in experimental and in silico datasets, and assess the limitations of each method.

AB - The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of complex phenotypes, much of the estimated heritability, or trait variability due to genetic factors, remain unexplained. We may be able to account for a portion of the missing heritability if we incorporate a systems biology approach into these analyses. Rapid technological advances will make it possible for scientists to explore this hypothesis via the generation of high-throughput omics data-transcriptomic, proteomic and methylomic to name a few. Analyzing this 'meta-dimensional data will require clever statistical techniques that allow for the integration of qualitative and quantitative predictor variables. For this article, we examine two major categories of approaches for integrated data analysis, give examples of their use in experimental and in silico datasets, and assess the limitations of each method.

UR - http://www.scopus.com/inward/record.url?scp=84855945426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855945426&partnerID=8YFLogxK

U2 - 10.2217/pgs.11.145

DO - 10.2217/pgs.11.145

M3 - Review article

C2 - 22256870

AN - SCOPUS:84855945426

VL - 13

SP - 213

EP - 222

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 2

ER -